XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Stockholders’ Equity - USD ($)
Total
Adoption of Accounting Standards Update No. 2016-13
Common Stock
Additional Paid-in Capital
Stock Subscriptions
Treasury Stock, At Cost
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Accumulated Deficit
Adoption of Accounting Standards Update No. 2016-13
Beginning balance (in shares) at Dec. 31, 2021 [1]     5,374,499            
Beginning balance at Dec. 31, 2021 $ 37,792,038   $ 2,044 $ 168,338,673 $ (18,545) $ (3,691,322) $ 563,911 $ (127,402,723)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Equity based compensation $ 7,674,265     7,674,265          
Stock option exercises (in shares) 79,724   44,362 [1]            
Stock option exercises $ 100,370   $ 17 100,353          
Restricted stock issuances and vesting of awards (in shares) [1]     35,513            
Restricted stock issuances and vesting of awards 2,635,270   $ 13 2,635,257          
Stock subscriptions receivable related to stock option exercises (in shares) [1]     35,362            
Stock subscriptions receivable related to stock option exercises 0   $ 13 305,820 (305,833)        
Stock subscriptions collected related to stock option exercises 324,378       324,378        
Repurchase of common stock (in shares) [1]     (11,266)            
Repurchase of common stock (381,434)   $ (4)     (381,430)      
Foreign currency translation adjustment (1,207,885)           (1,207,885)    
Net (loss) income $ (38,093,756)             (38,093,756)  
Ending balance (in shares) at Dec. 31, 2022 5,478,470   5,478,470 [1]            
Ending balance at Dec. 31, 2022 $ 8,843,246 [2] $ 878,577 $ 2,083 179,054,368 0 (4,072,752) (643,974) (165,496,479) $ 878,577
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-13 [Member]                
Issuance of additional shares related to reverse stock split (in shares)     6,245            
Equity based compensation $ 3,313,659     3,313,659          
Stock option exercises (in shares) 16,343   16,343 [1]            
Stock option exercises $ 26,996     26,996          
Restricted stock issuances and vesting of awards (in shares) [1]     296,510            
Restricted stock issuances and vesting of awards 3,620,059   $ 3 3,620,056          
Repurchase of common stock (in shares) [1]     (100,051)            
Repurchase of common stock (1,683,210)   $ (1)     (1,683,209)      
Foreign currency translation adjustment (3,025)           (3,025)    
Net (loss) income $ 7,098,022             7,098,022  
Ending balance (in shares) at Dec. 31, 2023 5,697,517   5,697,517 [1]            
Ending balance at Dec. 31, 2023 $ 22,094,324 [2]   $ 2,085 $ 186,015,079 $ 0 $ (5,755,961) $ (646,999) $ (157,519,880)  
[1] Effective May 11, 2023, we performed a 1-for-38 reverse stock split. Share amounts have been retroactively restated.
[2] Effective May 11, 2023, we performed a 1-for-38 reverse stock split. Share amounts (excluding shares authorized and par value) have been retroactively restated.